Literature DB >> 28504924

mRNA expression of nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors in colorectal carcinoma.

Venus Zafari1, Shahryar Hashemzadeh, Mohammadali Hosseinpour Feizi, Nasser Pouladi, Leila Rostami Zadeh, Ebrahim Sakhinia.   

Abstract

Transcription factors are involved in cell cycle and apoptosis regulation and thus have a key role in the carcinogenesis of different tumors. Nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors are important in the carcinogenesis of colorectal cancer (CRC). In this study, we examined whether the expression of NFATc2 and PPARG genes is significantly altered during the carcinogenesis of CRC. A total of 47 tumor samples and matched normal tissue margins were collected during surgery from patients with CRC. In addition, three CRC cell lines (HCT119, SW480, and HT29) and healthy cell line were used. After total RNA extraction and cDNA synthesis, mRNA expression levels of NFATc2 and PPARG were examined by real-time polymerase chain reaction. The results showed that NFATc2 is overexpressed in the tumor tissues compared with normal tissue margins (p ≤ 0.05). However, the mRNA expression levels of PPARG were not significantly different between the tumor tissues and tissue margins. Our results indicate that NFATc2 may be used as an early diagnostic or predictive biomarker for CRC as well as a therapeutic target, providing that upcoming studies confirm these results.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28504924      PMCID: PMC5581975          DOI: 10.17305/bjbms.2017.1886

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  46 in total

Review 1.  NFAT proteins: key regulators of T-cell development and function.

Authors:  Fernando Macian
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

2.  Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.

Authors:  Lie Yang; Hong Zhang; Zong-Guang Zhou; Hui Yan; G Adell; Xiao-Feng Sun
Journal:  Clin Cancer Res       Date:  2011-04-29       Impact factor: 12.531

Review 3.  Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.

Authors:  Naoko Takebe; Pamela J Harris; Ronald Q Warren; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2010-12-14       Impact factor: 66.675

4.  Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2.

Authors:  Javier Duque; Manuel Fresno; Miguel A Iñiguez
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

5.  NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.

Authors:  Alexander Köenig; Thomas Linhart; Katrin Schlengemann; Kristina Reutlinger; Jessica Wegele; Guido Adler; Garima Singh; Leonie Hofmann; Steffen Kunsch; Thomas Büch; Eva Schäfer; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Gastroenterology       Date:  2009-11-06       Impact factor: 22.682

6.  Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia.

Authors:  Vanesa Martín; Ana Valencia; Xabier Agirre; Jose Cervera; Edurne San Jose-Eneriz; Amaia Vilas-Zornoza; Paula Rodriguez-Otero; Miguel A Sanz; Concepción Herrera; Antonio Torres; Felipe Prosper; Jose Román-Gómez
Journal:  Cancer Sci       Date:  2009-10-29       Impact factor: 6.716

7.  PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.

Authors:  John S Welch; Mercedes Ricote; Taro E Akiyama; Frank J Gonzalez; Christopher K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

8.  Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability.

Authors:  Min Sung Kim; Sung Soo Kim; Chang Hyeok Ahn; Nam Jin Yoo; Sug Hyung Lee
Journal:  Hum Pathol       Date:  2008-08-27       Impact factor: 3.466

9.  PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.

Authors:  Lina Sabatino; Alessandra Fucci; Massimo Pancione; Vittorio Colantuoni
Journal:  PPAR Res       Date:  2012-07-16       Impact factor: 4.964

10.  Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.

Authors:  Shuji Ogino; Kaori Shima; Yoshifumi Baba; Katsuhiko Nosho; Natsumi Irahara; Shoko Kure; Li Chen; Saori Toyoda; Gregory J Kirkner; Y Lynn Wang; Edward L Giovannucci; Charles S Fuchs
Journal:  Gastroenterology       Date:  2008-12-24       Impact factor: 33.883

View more
  3 in total

1.  NFATC2 is a novel therapeutic target for colorectal cancer stem cells.

Authors:  Tingyuan Lang; Xiaojuan Ding; Liangsheng Kong; Xiaoyan Zhou; Zhiqi Zhang; Huangxian Ju; Shijia Ding
Journal:  Onco Targets Ther       Date:  2018-10-15       Impact factor: 4.147

Review 2.  Antitumor pharmacotherapy of colorectal cancer in kidney transplant recipients.

Authors:  Yuanyuan Fu; Chengheng Liao; Kai Cui; Xiao Liu; Wentong Fang
Journal:  Ther Adv Med Oncol       Date:  2019-09-23       Impact factor: 8.168

3.  Aberrant Expression of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer and Their Association with Cancer Progression and Prognosis.

Authors:  Musa Yaghoubizadeh; Leila Pishkar; Gholam Basati
Journal:  Gastrointest Tumors       Date:  2019-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.